PubRank

Robert Goldsby

Author PubWeight™ 25.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol 2007 1.73
2 Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011 1.67
3 Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007 1.62
4 Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2012 1.55
5 Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol 2009 1.25
6 Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. Addiction 2008 1.22
7 Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging 2008 1.14
8 Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2010 1.12
9 Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation. Cancer Epidemiol Biomarkers Prev 2011 1.04
10 Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw 2014 0.98
11 Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int J Radiat Oncol Biol Phys 2009 0.97
12 Unexpected pleural effusions in 3 pediatric patients treated with STI-571. J Pediatr Hematol Oncol 2002 0.88
13 Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging. Pediatr Radiol 2010 0.88
14 Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer 2011 0.87
15 Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician. Cleve Clin J Med 2008 0.85
16 Adverse impact of regional lymph node involvement in osteosarcoma. Eur J Cancer 2013 0.84
17 Osteosarcoma in children 5 years of age or younger at initial diagnosis. Pediatr Blood Cancer 2010 0.83
18 Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma. Pediatr Blood Cancer 2011 0.83
19 Clinical features and outcomes in patients with secondary Ewing sarcoma. Pediatr Blood Cancer 2012 0.81
20 Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2011 0.81
21 Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement. Pediatr Blood Cancer 2011 0.80
22 Pediatric malignancies. Case 2. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease. J Clin Oncol 2005 0.80
23 Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 2003 0.79
24 Evaluation of plasma annexin V levels in children and young adults with solid tumors. Int J Biol Markers 2012 0.75
25 Comparison of Latino and non-Latino patients with Ewing sarcoma. Pediatr Blood Cancer 2013 0.75
26 Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT. Radiol Case Rep 2016 0.75
27 Immunotherapy for severe aplastic anemia following orthotopic liver transplantation in children. Pediatr Blood Cancer 2007 0.75
28 Dapsone therapy for children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2003 0.75